VUNO Med
AI-powered medical imaging analysis platform for radiology and ophthalmology
Platform · HybridCompany source
Company profile
About VUNO
VUNO is a leading medical artificial intelligence company based in South Korea that develops deep learning-based solutions for medical imaging analysis and clinical decision support. The company focuses on creating AI-powered diagnostic tools that assist healthcare professionals in detecting and analyzing various medical conditions through advanced image recognition and predictive analytics. VUNO's product portfolio spans multiple clinical specialties including radiology, ophthalmology, and critical care, with solutions designed to improve diagnostic accuracy, workflow efficiency, and patient outcomes. The company's technology leverages convolutional neural networks and other advanced AI methodologies to analyze medical images such as chest X-rays, CT scans, and fundus photographs. VUNO serves hospitals, clinics, and healthcare systems primarily in Asia, with a growing international presence. The company has received multiple regulatory clearances and certifications for its medical AI products and maintains partnerships with major healthcare institutions and technology companies to advance the adoption of AI in clinical practice.
Company description VUNO official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at VUNO?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- bone fractures
- cardiovascular conditions
- chest diseases
- critical care conditions
- diabetic retinopathy
Who it serves
- Clinics
- Health Systems
- Hospitals
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsAsia · South Korea
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Prediction of Atrial Fibrillation Occurrence With Handheld Mobile Electrocardiogram: Deep Learning Model Development Using Real-World Data.JMIR medical informatics · Aug 20, 2026
Efficacy and Long-Term Outcomes of Direct-Acting Antivirals in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Gut and liver · Jun 30, 2026
Deep learning-based natural language processing for critical care identification in pediatric emergency department.BMC emergency medicine · Jun 16, 2026
Position-wise comparison of handheld 6-lead ECG versus the standard 12-lead ECG in patients with arrhythmia: comparative study.BMC cardiovascular disorders · Jun 8, 2026
Development and validation of a deep learning-based automatic segmentation and classification of cerebral white matter hyperintensities.European radiology · Jun 1, 2026
Implementation of an AI-Based Clinical Decision Support System Predicting In-Hospital Cardiac Arrest in General Wards: A Multicenter Staggered-Implementation Study in Secondary Hospitals in Korea.Diagnostics (Basel, Switzerland) · May 29, 2026
Clinical validation
Clinical-trial records
AI ECG Algorithm for Detecting LV Systolic DysfunctionNCT07636759 · Sponsor · RECRUITING
Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal StudyNCT07712952 · Sponsor · COMPLETED
Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest RadiographyNCT07686562 · Sponsor · COMPLETED
Regulatory
Regulatory records
VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link TriageK241439 · 510k · Nov 15, 2024
VUNO Med-DeepBrainK231398 · 510k · Oct 4, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from VUNO
Recent articles published on VUNO's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.